Relief of bowel-related symptoms with telotristat etiprate in octreotide refractory carcinoid syndrome: Preliminary results of a double-blind, placebo-controlled multicenter study.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Iowa Hospitals and Clinics, The University of Texas MD Anderson Cancer Center, Texas Oncology, St. Francis Hospital, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Lexicon Pharmaceuticals (United States), Brigham and Women's Hospital, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2590831073